awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33614337-497B56B7-E55C-4743-B25D-FBDA5592CFFA
Q33614337-497B56B7-E55C-4743-B25D-FBDA5592CFFA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33614337-497B56B7-E55C-4743-B25D-FBDA5592CFFA
Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial
P2860
Q33614337-497B56B7-E55C-4743-B25D-FBDA5592CFFA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33614337-497B56B7-E55C-4743-B25D-FBDA5592CFFA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
aa52a47212603d7b371e303ea7b1dc8bf79292a6
P2860
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus